PMID- 19417173 OWN - NLM STAT- MEDLINE DCOM- 20091102 LR - 20111117 IS - 1469-0756 (Electronic) IS - 0032-5473 (Linking) VI - 85 IP - 1002 DP - 2009 Apr TI - Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus. PG - 219-22 LID - 10.1136/pgmj.2008.073379 [doi] AB - Some patients with type 2 diabetes mellitus (T2DM) are profoundly insulin resistant and require large insulin doses to achieve optimal glycaemic control. However, large volumes of subcutaneous conventional U-100 insulin can cause discomfort at the injection site, resulting in poor concordance with insulin therapy. One therapeutic option is the use of U-500 insulin, thus reducing the insulin volume by 80%. This review will address the practical issues associated with the use of U-500, clinical efficacy and safety aspects of this concentrated insulin, which has an important role in a subgroup of patients with T2DM. FAU - Crasto, W AU - Crasto W AD - Department of Diabetes and Endocrinology, University Hospitals of Leicester NHS Trust, UK. FAU - Jarvis, J AU - Jarvis J FAU - Hackett, E AU - Hackett E FAU - Nayyar, V AU - Nayyar V FAU - McNally, P G AU - McNally PG FAU - Davies, M J AU - Davies MJ FAU - Lawrence, I G AU - Lawrence IG LA - eng PT - Journal Article PT - Review PL - England TA - Postgrad Med J JT - Postgraduate medical journal JID - 0234135 RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin) SB - IM MH - Diabetes Mellitus, Type 2/complications/*drug therapy/economics MH - Drug Costs MH - Humans MH - Hypoglycemic Agents/*administration & dosage/adverse effects/economics MH - Insulin/*administration & dosage/adverse effects/economics MH - Insulin Resistance/*physiology MH - Obesity/complications MH - Patient Satisfaction MH - Treatment Outcome MH - Weight Gain RF - 25 EDAT- 2009/05/07 09:00 MHDA- 2009/11/03 06:00 CRDT- 2009/05/07 09:00 PHST- 2009/05/07 09:00 [entrez] PHST- 2009/05/07 09:00 [pubmed] PHST- 2009/11/03 06:00 [medline] AID - 85/1002/219 [pii] AID - 10.1136/pgmj.2008.073379 [doi] PST - ppublish SO - Postgrad Med J. 2009 Apr;85(1002):219-22. doi: 10.1136/pgmj.2008.073379.